-
1
-
-
0028345241
-
Advances in the epidemiology of gestational trophoblastic disease
-
Palmer JR: Advances in the epidemiology of gestational trophoblastic disease. J Reprod Med 1994;39:155-162
-
(1994)
J Reprod Med
, vol.39
, pp. 155-162
-
-
Palmer, J.R.1
-
2
-
-
0242691792
-
Epidemiology and aetiology of gestational trophoblastic diseases
-
Altieri A, Franceschi S, Ferlay J, et al: Epidemiology and aetiology of gestational trophoblastic diseases. Lancet Oncol 2003;4:670-678
-
(2003)
Lancet Oncol
, vol.4
, pp. 670-678
-
-
Altieri, A.1
Franceschi, S.2
Ferlay, J.3
-
3
-
-
0022547902
-
Hydatidiform mole in England and Wales 1973-83
-
Bagshawe KD, Dent J, Webb J: Hydatidiform mole in England and Wales 1973-83. Lancet 1986;2:673-677
-
(1986)
Lancet
, vol.2
, pp. 673-677
-
-
Bagshawe, K.D.1
Dent, J.2
Webb, J.3
-
4
-
-
0020656089
-
Natural history of hydatidiform mole after primary evacuation
-
Lurain JR, Brewer JI, Torok EE, et al: Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 1983;145:591-595
-
(1983)
Am J Obstet Gynecol
, vol.145
, pp. 591-595
-
-
Lurain, J.R.1
Brewer, J.I.2
Torok, E.E.3
-
6
-
-
0028862073
-
The changing clinical presentation of complete molar pregnancy
-
Soto-Wright V, Bernstein M, Goldstein DP, et al: The changing clinical presentation of complete molar pregnancy. Obstet Gynecol 1995;86:775-779
-
(1995)
Obstet Gynecol
, vol.86
, pp. 775-779
-
-
Soto-Wright, V.1
Bernstein, M.2
Goldstein, D.P.3
-
7
-
-
0029885043
-
Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy
-
Roberts JP, Lurain JR: Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 1996;17:1917-1923
-
(1996)
Am J Obstet Gynecol
, vol.17
, pp. 1917-1923
-
-
Roberts, J.P.1
Lurain, J.R.2
-
8
-
-
0036534303
-
Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000
-
McNeish IA, Strickland S, Holden L, et al: Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002;20:1838-1844
-
(2002)
J Clin Oncol
, vol.20
, pp. 1838-1844
-
-
McNeish, I.A.1
Strickland, S.2
Holden, L.3
-
9
-
-
33750218149
-
Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience
-
Sekharan PK, Sreedevi NS, Radhadevi VP, et al: Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience. J Reprod Med 2006;51:835-840
-
(2006)
J Reprod Med
, vol.51
, pp. 835-840
-
-
Sekharan, P.K.1
Sreedevi, N.S.2
Radhadevi, V.P.3
-
10
-
-
0036623106
-
Clinical characteristics of gestational trophoblastic disease at a single institute
-
Alici S, Eralp Y, Saip P, et al: Clinical characteristics of gestational trophoblastic disease at a single institute. Tohoku J Exp Med 2002;197:95-100
-
(2002)
Tohoku J Exp Med
, vol.197
, pp. 95-100
-
-
Alici, S.1
Eralp, Y.2
Saip, P.3
-
11
-
-
33751245927
-
Gestational trophoblastic neoplasia: Clinical trends in 8 years at Hospital Universitario de Caracas
-
Cortés-Charry R, Figueira LM, García-Barriola V, et al: Gestational trophoblastic neoplasia: Clinical trends in 8 years at Hospital Universitario de Caracas. J Reprod Med 2006;51: 888-891
-
(2006)
J Reprod Med
, vol.51
, pp. 888-891
-
-
Cortés-Charry, R.1
Figueira, L.M.2
García-Barriola, V.3
-
12
-
-
0034041479
-
Review of trophoblastic disease at Taipei Veterans General Hospital
-
Wang JC, Wang PH, Yuan CC: Review of trophoblastic disease at Taipei Veterans General Hospital. Zhonghua Yi Xue Za Zhi (Taipei) 2000;63:399-406
-
(2000)
Zhonghua Yi Xue Za Zhi (Taipei)
, vol.63
, pp. 399-406
-
-
Wang, J.C.1
Wang, P.H.2
Yuan, C.C.3
-
13
-
-
0024371428
-
The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT)
-
Bagshawe KD, Dent J, Newlands ES, et al: The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 1989;96:795-802
-
(1989)
Br J Obstet Gynaecol
, vol.96
, pp. 795-802
-
-
Bagshawe, K.D.1
Dent, J.2
Newlands, E.S.3
-
14
-
-
0030757259
-
EMA/CO for highrisk gestational trophoblastic tumors: Results from a cohort of 272 patients
-
Bower M, Newlands ES, Holden L, et al: EMA/CO for highrisk gestational trophoblastic tumors: Results from a cohort of 272 patients. J Clin Oncol 1997;15:2636-2643
-
(1997)
J Clin Oncol
, vol.15
, pp. 2636-2643
-
-
Bower, M.1
Newlands, E.S.2
Holden, L.3
-
15
-
-
0033982236
-
Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors
-
Newlands ES, Mulholland PJ, Holden L, et al: Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000;18:854-859
-
(2000)
J Clin Oncol
, vol.18
, pp. 854-859
-
-
Newlands, E.S.1
Mulholland, P.J.2
Holden, L.3
-
16
-
-
25144505680
-
The curative effect of a second curettage in persistent trophoblastic disease: A retrospective cohort survey
-
Garner EI, Feltmate CM, Goldstein DP, et al: The curative effect of a second curettage in persistent trophoblastic disease: A retrospective cohort survey. Gynecol Oncol 2005;99:3-5
-
(2005)
Gynecol Oncol
, vol.99
, pp. 3-5
-
-
Garner, E.I.1
Feltmate, C.M.2
Goldstein, D.P.3
-
17
-
-
0036284589
-
FIGO staging for gestational trophoblastic neoplasia
-
FIGO Oncology Committee
-
FIGO Oncology Committee: FIGO staging for gestational trophoblastic neoplasia. Int J Gynaecol Obstet 2002;77:285-287
-
(2002)
Int J Gynaecol Obstet
, vol.77
, pp. 285-287
-
-
-
18
-
-
2942644607
-
Diagnosis and treatment of gestational trophoblastic disease
-
ACOG Practice Bulletin 53
-
ACOG Practice Bulletin 53: Diagnosis and treatment of gestational trophoblastic disease. Gynecol Oncol 2004;93:575-585
-
(2004)
Gynecol Oncol
, vol.93
, pp. 575-585
-
-
-
19
-
-
25144495095
-
Second curettage in persistent trophoblastic disease (FTD): The need for univocal definition of PTD
-
van Trommel NE, Thomas CM, Massuger LF, et al: Second curettage in persistent trophoblastic disease (FTD): The need for univocal definition of PTD. Gynecol Oncol 2005;99:250-251
-
(2005)
Gynecol Oncol
, vol.99
, pp. 250-251
-
-
van Trommel, N.E.1
Thomas, C.M.2
Massuger, L.F.3
-
20
-
-
9944238410
-
The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease
-
Pezeshki M, Hancock BW, Silcocks P, et al: The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease. Gynecol Oncol 2004;95:423-429
-
(2004)
Gynecol Oncol
, vol.95
, pp. 423-429
-
-
Pezeshki, M.1
Hancock, B.W.2
Silcocks, P.3
-
21
-
-
25144465374
-
The role of repeat uterine evacuation in trophoblast disease
-
Savage P, Seckl MJ: The role of repeat uterine evacuation in trophoblast disease. Gynecol Oncol 2005;99:251-252
-
(2005)
Gynecol Oncol
, vol.99
, pp. 251-252
-
-
Savage, P.1
Seckl, M.J.2
-
24
-
-
4344685950
-
What is the best regimen for low-risk gestational trophoblastic neoplasia? A review
-
Osborne R, Gerulath A: What is the best regimen for low-risk gestational trophoblastic neoplasia? A review. J Reprod Med 2004;49:602-616
-
(2004)
J Reprod Med
, vol.49
, pp. 602-616
-
-
Osborne, R.1
Gerulath, A.2
-
25
-
-
0002725326
-
Treatment of metastatic gestational trophoblastic tumors
-
Edited by BW Hancock, ES Newlands, R Berkowitz. London, Chapman & Hall
-
Lurain JR: Treatment of metastatic gestational trophoblastic tumors. In Gestational Trophoblastic Disease. Edited by BW Hancock, ES Newlands, R Berkowitz. London, Chapman & Hall, 1997, pp 199-209
-
(1997)
Gestational Trophoblastic Disease
, pp. 199-209
-
-
Lurain, J.R.1
-
26
-
-
0022560715
-
Ten years'experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease
-
Berkowitz RS, Goldstein DP, Bernstein MR: Ten years'experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986; 23:111-118
-
(1986)
Gynecol Oncol
, vol.23
, pp. 111-118
-
-
Berkowitz, R.S.1
Goldstein, D.P.2
Bernstein, M.R.3
-
27
-
-
13844280396
-
Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy
-
Matsui H, Suzuka K, Yamazawa K, et al: Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy. Gynecol Oncol 2005;96:616-620
-
(2005)
Gynecol Oncol
, vol.96
, pp. 616-620
-
-
Matsui, H.1
Suzuka, K.2
Yamazawa, K.3
-
28
-
-
0023742415
-
Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia
-
Rotmensch J, Rosenshein NB, Block BS: Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol 1988;29:82-86
-
(1988)
Gynecol Oncol
, vol.29
, pp. 82-86
-
-
Rotmensch, J.1
Rosenshein, N.B.2
Block, B.S.3
-
29
-
-
33644843640
-
Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease
-
van Trommel NE, Massuger LF, Schijf CP, ten Kate-Booij MJ, Sweep FC, Thomas CM: Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease. J Clin Oncol 2006;24:452-58
-
(2006)
J Clin Oncol
, vol.24
, pp. 452-458
-
-
van Trommel, N.E.1
Massuger, L.F.2
Schijf, C.P.3
ten Kate-Booij, M.J.4
Sweep, F.C.5
Thomas, C.M.6
-
30
-
-
0017138758
-
Risk and prognostic factors in trophoblastic neoplasia
-
Bagshawe KD: Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1373-1385
-
(1976)
Cancer
, vol.38
, pp. 1373-1385
-
-
Bagshawe, K.D.1
-
31
-
-
0003635670
-
Gestational trophoblastic disease
-
World Health Organization
-
World Health Organization: Gestational trophoblastic disease. WHO Tech Rep Ser 692, 1983
-
(1983)
WHO Tech Rep Ser
, vol.692
-
-
-
32
-
-
0038395984
-
Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic disease
-
Khanlian SA, Smith HO, Cole LA: Persistent low levels of human chorionic gonadotropin: A premalignant gestational trophoblastic disease. Am J Obstet Gynecol 2003;188:1254-1259
-
(2003)
Am J Obstet Gynecol
, vol.188
, pp. 1254-1259
-
-
Khanlian, S.A.1
Smith, H.O.2
Cole, L.A.3
-
33
-
-
33745885034
-
Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results
-
Cole LA, Khanlian SA, Giddings A, et al: Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results. Gynecol Oncol 2006;102:165-172
-
(2006)
Gynecol Oncol
, vol.102
, pp. 165-172
-
-
Cole, L.A.1
Khanlian, S.A.2
Giddings, A.3
-
34
-
-
33847721452
-
A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
-
Powles T, Savage PM, Stebbing J, et al: A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia. Br J Cancer 2007;96:732-737
-
(2007)
Br J Cancer
, vol.96
, pp. 732-737
-
-
Powles, T.1
Savage, P.M.2
Stebbing, J.3
-
35
-
-
33750491919
-
The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours
-
Powles T, Young A, Sanitt A, et al: The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours. Br J Cancer 2006;95:1145-1147
-
(2006)
Br J Cancer
, vol.95
, pp. 1145-1147
-
-
Powles, T.1
Young, A.2
Sanitt, A.3
-
36
-
-
0037219647
-
Risk of recurrent hydatidifonn mole and subsequent pregnancy outcome following complete or partial hydatidifonn molar pregnancy
-
Sebire NJ, Fisher RA, Foskett M, et al: Risk of recurrent hydatidifonn mole and subsequent pregnancy outcome following complete or partial hydatidifonn molar pregnancy. BJOG 2003;110:22-26
-
(2003)
BJOG
, vol.110
, pp. 22-26
-
-
Sebire, N.J.1
Fisher, R.A.2
Foskett, M.3
-
37
-
-
0034969313
-
Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidifonn mole: Comparison between complete and partial mole
-
Matsui H, Iitsuka Y, Suzuka K, et al: Subsequent pregnancy outcome in patients with spontaneous resolution of HCG after evacuation of hydatidifonn mole: Comparison between complete and partial mole. Hum Reprod 2001;16:1274-1277
-
(2001)
Hum Reprod
, vol.16
, pp. 1274-1277
-
-
Matsui, H.1
Iitsuka, Y.2
Suzuka, K.3
-
38
-
-
0031884104
-
Gestational trophoblastic disease: Subsequent pregnancy outcome, including repeat molar pregnancy
-
Berkowitz RS, Im SS, Bernstein MR, et al: Gestational trophoblastic disease: Subsequent pregnancy outcome, including repeat molar pregnancy. J Reprod Med 1998;43:81-86
-
(1998)
J Reprod Med
, vol.43
, pp. 81-86
-
-
Berkowitz, R.S.1
Im, S.S.2
Bernstein, M.R.3
|